AAAAAA

   
Results: 1-13 |
Results: 13

Authors: ISKEDJIAN M HUX M REMINGTON GJ
Citation: M. Iskedjian et al., THE CANADIAN EXPERIENCE WITH RISPERIDONE FOR THE TREATMENT OF SCHIZOPHRENIA - AN OVERVIEW, Journal of psychiatry & neuroscience, 23(4), 1998, pp. 229-239

Authors: ISKEDJIAN M EINARSON TR
Citation: M. Iskedjian et Tr. Einarson, METAANALYSES OF CISAPRIDE, OMEPRAZOLE AND RANITIDINE IN THE TREATMENTOF GORD - IMPLICATIONS FOR TREATING PATIENT SUBGROUPS, Clinical drug investigation, 16(1), 1998, pp. 9-18

Authors: MITTMANN N TRAKAS K ISKEDJIAN M BRADLEY CA EINARSON TR
Citation: N. Mittmann et al., A PROPOSAL FOR STRUCTURED ABSTRACTS OF HEALTH ECONOMIC-STUDIES, The Annals of pharmacotherapy, 32(11), 1998, pp. 1244-1246

Authors: ISKEDJIAN M EINARSON TR FASSOS FF
Citation: M. Iskedjian et al., PHARMACOECONOMIC ASPECTS OF VENLAFAXINE, Reviews in contemporary pharmacotherapy, 9(5), 1998, pp. 345-353

Authors: HUX MJ OBRIEN BJ ISKEDJIAN M GOEREE R GAGNON M GAUTHIER S
Citation: Mj. Hux et al., RELATION BETWEEN SEVERITY OF ALZHEIMERS-DISEASE AND COSTS OF CARING, CMAJ. Canadian Medical Association journal, 159(5), 1998, pp. 457-465

Authors: OBRIEN B GOEREE R HUX M ISKEDJIAN M BLACKHOUSE G GAUTHIER S GAGNON M
Citation: B. Obrien et al., ECONOMIC-EVALUATION OF DONEPEZIL FOR TREATMENT OF ALZHEIMERS-DISEASE IN CANADA, Medical decision making, 18(4), 1998, pp. 482-482

Authors: OBRIEN B GOEREE R HUX M ISKEDJIAN M BLACKHOUSE G GAUTHIER S GAGNON M
Citation: B. Obrien et al., ECONOMIC-EVALUATION OF DONEPEZIL (D) FOR ALZHEIMERS-DISEASE IN CANADA, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 94-94

Authors: ISKEDJIAN M TRAKAS K BRADLEY CA ADDIS A LANCTOT K KRUK D ILERSICH AL EINARSON TR
Citation: M. Iskedjian et al., QUALITY ASSESSMENT OF ECONOMIC EVALUATIONS PUBLISHED IN PHARMACOECONOMICS - THE FIRST 4 YEARS (1992 TO 1995), PharmacoEconomics, 12(6), 1997, pp. 685-694

Authors: EINARSON TR ADDIS A ISKEDJIAN M
Citation: Tr. Einarson et al., PHARMACOECONOMIC ANALYSIS OF VENLAFAXINE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER, PharmacoEconomics, 12(2), 1997, pp. 286-296

Authors: AGRO KE BRADLEY CA MITTMANN N ISKEDJIAN M ILERSICH AL EINARSON TR
Citation: Ke. Agro et al., SENSITIVITY ANALYSIS IN HEALTH ECONOMIC AND PHARMACOECONOMIC STUDIES - AN APPRAISAL OF THE LITERATURE, PharmacoEconomics, 11(1), 1997, pp. 75-88

Authors: TRAKAS K ADDIS A KRUK D BUCZEK Y ISKEDJIAN M EINARSON TR
Citation: K. Trakas et al., QUALITY ASSESSMENT OF PHARMACOECONOMIC ABSTRACTS OF ORIGINAL RESEARCHARTICLES IN SELECTED JOURNALS, The Annals of pharmacotherapy, 31(4), 1997, pp. 423-428

Authors: MITTMANN N LIU BA ISKEDJIAN M BRADLEY CA PLESS R SHEAR NH EINARSON TR
Citation: N. Mittmann et al., DRUG-RELATED MORTALITY IN CANADA (1984-1994), Pharmacoepidemiology and drug safety, 6(3), 1997, pp. 157-168

Authors: BRADLEY CA ISKEDJIAN M LANCTOT KL MITTMANN N SIMONE C STPIERRE E MILLER E BLATMAN B CHABURSKY B EINARSON TR
Citation: Ca. Bradley et al., QUALITY ASSESSMENT OF ECONOMIC EVALUATIONS IN SELECTED PHARMACY, MEDICAL, AND HEALTH ECONOMICS JOURNALS, The Annals of pharmacotherapy, 29(7-8), 1995, pp. 681-689
Risultati: 1-13 |